The effect of parathyroidectomy on bone mineral density in primary hyperparathyroidism

The effect of parathyroidectomy on bone mineral density in primary hyperparathyroidism

Background/aim: This study aimed to investigate the change in bone mineral density (BMD) before and 1 year after parathyroidectomyin patients with primary hyperparathyroidism (PHPT).Materials and methods: The clinical and biochemical parameters and DEXA screening of patients with symptomatic PHPT (n = 28)and asymptomatic PHPT (n = 63) were investigated before and 1 year after parathyroidectomy.Results: Patients with symptomatic PHPT had a higher prevalence of nephrolithiasis (18.2% vs. 4.6%, P = 0.032) when compared to theprevalence in patients with asymptomatic PHPT. The prevalence of osteoporosis in the lumbar spine (63.0% vs. 37.5%, P = 0.026) andfemoral neck (40.7% vs. 20.6%, P = 0.048) was higher in symptomatic PHPT when compared to the prevalence in asymptomatic PHPT.After parathyroidectomy, the decreases in the prevalence of osteoporosis in the lumbar spine (25.8% vs. 9.4%, P = 0.014), femoral neck(22.1% vs. 8.2%, P =0.009), and total hip (22.4% vs. 5.3%, P = 0.007) were higher in symptomatic PHPT compared to the asymptomaticPHPT group. A higher BMD gain (g/cm2) was seen in the lumbar spine (10.83% vs. 4.65%, P=0.016) and femoral neck (12.61% vs.4.37%, P=0.005) in symptomatic PHPT compared to the asymptomatic PHPT group.Conclusion: Parathyroidectomy provided more BMD gain in the lumbar spine and femoral neck in patients with symptomatic PHPTwhen compared to patients with asymptomatic PHPT 1 year after parathyroidectomy.

___

  • 1. Cordellat IM. Hyperparathyroidism: primary or secondary disease? Reumatologia Clinica 2012; 8 (5): 287-91. doi: 10.1016/j.reuma.2011.06.001
  • 2. Silverberg SJ, Clarke BL, Peacock M, Bandeira F, Boutroy S et al. Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. Journal of Clinical Endocrinology and Metabolism 2014; 99 (10): 3580-3894. doi: 10.1210/jc.2014-1415
  • 3. Bandeira F, Cusano NE, Silva BC, Cassibba S, Almeida CB et al. Bone disease in primary hyperparathyroidism. Arquvios Brasileiros de Endocrinologia and Metabologia 2014; 58 (5): 553-361. doi: 10.1590/0004-2730000003381
  • 4. Vestergaard P, Mosekilde L. Fractures in patients with primary hyperparathyroidism: nationwide follow-up study of 1201 patients. World Journal of Surgery 2003; 27: 343-349. doi: 10.1007/s00268-002-6589-9
  • 5. Yu N, Donnan PT, Flynn RWV, Murphy MJ, Smith D et al. Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS). Clinical Endocrinology 2010; 73: 30-34. doi: 10.1111/j.1365-2265.2009.03766.x
  • 6. Roschger P, Dempster DW, Zhou H, Paschalis EP, Silverberg SJ et al. New observations on bone quality in mild primary hyperparathyroidism as determined by quantitative backscattered electron imaging. Journal of Bone and Mineral Research 2007; 22: 717-723. doi: 10.1359/jbmr.070120
  • 7. Siilin H, Lundgren E, Mallmin H, Mellström D, Ohlsson C et al. Prevalence of primary hyperparathyroidism and impact on bone mineral density in elderly men: MrOs Sweden. World Journal of Surgery 2011; 35: 1266-1272. doi: 10.1007/s00268- 011-1062-2
  • 8. Vignali E, Viccica G, Diacinti D, Cetani F, Cianferotti L et al. Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2009; 94: 2306-2312. doi: 10.1210/jc.2008-2006
  • 9. Bandeira F, Griz L, Chaves N, Carvalho NC, Borges LM et al. Diagnosis and management of primary hyperparathyroidism--a scientific statement from the Department of Bone Metabolism, the Brazilian Society for Endocrinology and Metabolism. Arquivos Brasileiros de Endocrinologia and Metabologia 2013; 57: 406-424. doi: 10.1590/s0004-27302013000600002
  • 10. Tamura Y, Araki A, Chiba Y, Mori S, Hosoi T et al. Remarkable increase in lumbar spine bone mineral density and amelioration in biochemical markers of bone turnover after parathyroidectomy in elderly patients with primary hyperparathyroidism: a 5-year follow-up study. Journal of Bone and Mineral Metabolism 2007; 25: 226-231. doi: 10.1007/s00774-007-0754-z
  • 11. Rubin MR, Bilezikian JP, McMahon DJ, Jacobs T, Shane E et al. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. Journal of Clinical Endocrinology and Metabolism 2008; 93: 3462-3470. doi: 10.1210/jc.2007-1215
  • 12. Rao DS, Phillips ER, Divine GW, Talpos GB. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2004; 89: 5415-5422. doi: 10.1210/jc.2004-0028
  • 13. Vander Walde LH, Liu IL, Haigh PI. Effect of bone mineral density and parathyroidectomy on fracture risk in primary hyperparathyroidism. World Journal of Surgery 2009; 33: 406- 411. doi: 10.1007/s00268-008-9720-8
  • 14. Ambrogini E, Cetani F, Cianferotti L, Vignali E, Banti C et al. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. Journal of Clinical Endocrinology and Metabolism 2007; 92: 3114-3121. doi: 10.1210/jc.2007-0219
  • 15. Christiansen P. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture. Journal of Pathology, Microbiology and Immunology 2001; 102: 1-52. doi: 10.1111/j.1600-0463.2001.tb05399.x
  • 16. Nomura R, Sugimoto T, Tsukamoto T, Yamauchi M, Sowa H et al. Marked and sustained increase in bone mineral density after parathyroidectomy in patients with primary hyperparathyroidism; a six-year longitudinal study with or without parathyroidectomy in a Japanese population. Clinical Endocrinology 2004; 60: 335-342. doi: 10.1111/j.1365- 2265.2004.01984.x
  • 17. Thier M, Nordenström E, Bergenfelz A, Almquist M. Presentation and outcomes after surgery for primary hyperparathyroidism during an 18-year period. World Journal of Surgery 2016; 40: 356-364. doi: 10.1007/s00268-015-3329-5
  • 18. Rolighed L, Vestergaard P, Heickendorff L, Sikjaer T, Rejnmark L et al. BMD improvements after operation for primary hyperparathyroidism. Langenbeck’s Archives of Surgery 2013; 398: 113-120. doi: 10.1007/s00423-012-1026-5
  • 19. Marcocci C, Bollerslev J, Khan AA, Shoback DM. Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2014; 99: 3607-3618. doi: 10.1210/jc.2014-1417
  • 20. Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. Journal of Clinical Endocrinology and Metabolism 2014; 99: 3561-3569. doi: 10.1210/jc.2014-1413
  • 21. Hansen S, Beck Jensen JE, Rasmussen L, Hauge EM, Brixen K. Effects on bone geometry, density, and microarchitecture in the distal radius but not the tibia in women with primary hyperparathyroidism: a case-control study using HR-pQCT. Journal of Bone and Mineral Metabolism 2010; 25: 1941-1947. doi: 10.1002/jbmr.98
  • 22. Stein EM, Silva BC, Boutroy S, Zhou B, Wang J et al. Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women. Journal of Bone and Mineral Metabolism 2013; 28: 1029-1040. doi: 10.1002/jbmr.1841
  • 23. Lundstam K, Heck A, Mollerup C, Godang K, Baranowski M et al. Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2015; 100: 1359-1367. doi: 10.1210/jc.2014-3441
  • 24. Jung KY, Hong AR, Lee DH, Kim JH, Kim KM et al. The natural history and hip geometric changes of primary hyperparathyroidism without parathyroid surgery. Journal of Bone and Mineral Metabolism 2017; 35 (3): 278-288. doi: 10.1007/s00774-016-0751-1
  • 25. Zanocco K, Angelos P, Sturgeon C. Cost-effectiveness analysis of parathyroidectomy for asymptomatic primary hyperparathyroidism. Surgery 2006; 140 (6): 874-881. doi: 10.1016/j.surg.2006.07.032
  • 26. Bollerslev J, Jansson S, Mollerup CL, Nordenström J, Lundgren E et al. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. Journal of Clinical Endocrinology and Metabolism 2007; 92: 1687-1692. doi: 10.1210/jc.2006-1836
  • 27. Gianotti L, Tassone F, Baffoni C, Pellegrino M, Cassibba S et al. Relationship between insulin sensitivity and bone mineral density in primary hyperparathyroidism. Clinical Endocrinology 2014; 81: 350-355. doi: 10.1111/cen.12472
  • 28. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10- year prospective study of primary hyperparathyroidism with or without parathyroid surgery. New England Journal of Medicine 1999; 341: 1249-1255. doi: 10.1056/NEJM199910213411701
  • 29. Bandeira F, Cassibba S. Hyperparathyroidism and bone health. Current Rheumatology Reports 2015; 17: 48. doi: 10.1007/ s11926-015-0523-2
  • 30. Bandeira F, Griz L, Caldas G, Bandeira C, Freese E. From mild to severe primary hyperparathyroidism: the Brazilian experience. Arquivos Brasileiros de Endocrinologia e Metabologia 2006; 50: 657-663. doi: 10.1590/s0004-27302006000400011
  • 31. Silverberg SJ, Gartenberg F, Jacobs TP, Shane E, Siris E et al. Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 1995; 80: 729-734. doi: 10.1210/jcem.80.3.7883824
  • 32. Sankaran S, Gamble G, Bolland M, Reid IR, Grey A. Skeletal effects of interventions in mild primary hyperparathyroidism: a meta-analysis. Journal of Clinical Endocrinology and Metabolism 2010; 95; 1653-1662. doi: 10.1210/jc.2009-2384
  • 33. Calvi LM, Sims NA, Hunzelman JL, Knight MC, Giovannetti A, et al. Activated parathyroid hormone/parathyroid hormonerelated protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. Journal of Clinical Investigation 2001; 107: 277-286. doi: 10.1172/JCI11296
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Ömer KARACA, Hüseyin Ulaş PINAR, Ahmet Fevzi ÖZGÜR, Sevsen KULAKSIZOĞLU, Rafi DOĞAN

Does transrectal ultrasonography-guided biopsy of the prostate lead to possible further metastasis via circulating tumor cells?

Mahmut ULUBAY, Mustafa Kemal ATİLLA, Bahattin AVCI, Alper BİTKİN, Mevlüt KELEŞ, İnci YÜCEL, Lokman İRKILATA, Mustafa AYDIN

Assessment of the visual pathways in patients with neurofibromatosis-1 by 3S-space technique with 3-Tesla MRI

Ali VARAN, Banu ANLAR, Tülay KANSU, Mehmet BEYAZAL, Özge SARAÇ, Oktay ALGIN

Serkan GÖKASLAN, Çiğdem Özer GÖKASLAN, Emin DEMİREL, Sefa ÇELİK

Nilüfer Çetişli KORKMAZ, Mehmet DURAY, Esra Doğru HÜZMELİ, Hande ŞENOL

The effect of pregabalin on tourniquet-induced ischemia-reperfusion injury: a prospective randomized study

Ömer KARACA, Ahmet Fevzi ÖZGÜR, Sevsen KULAKSIZOĞLU, Rafi DOĞAN, Hüseyin Ulaş PINAR

Neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, and platelet-tolymphocyte ratio in different etiological causes of thyrotoxicosis

Mustafa Kemal KILIÇ, Çağatay Emir ÖNDER, Tülay OMMA, Cavit ÇULHA, Gönül KOÇ, Işılay TAŞKALDIRAN, Sevde Nur FIRAT, Şerife Mehlika KUŞKONMAZ

Göksel TUZCU, Ali Uğur USLU, Ayça TUZCU, Rabia Aydoğan BAYKARA, Ahmet OMMA, Adem KÜÇÜK

Mustafa Kemal ATİLLA, Bahattin AVCI, Lokman İRKILATA, Mustafa AYDIN, Alper BİTKİN, Mevlüt KELEŞ, İnci YÜCEL, Mahmut ULUBAY

Salih TOPAL, Burak SEZENÖZ, Mustafa CANDEMİR, Eser AÇIKGÖZ, Sadik Kadri AÇIKGÖZ, Nuri Bülent BOYACI